Advanced Search

Home > Journals > International Angiology > Past Issues > International Angiology 1998 September;17(3) > International Angiology 1998 September;17(3):155-60

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEINTERNATIONAL ANGIOLOGY

A Journal on Angiology

Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,899

Frequency: Bi-Monthly

ISSN 0392-9590

Online ISSN 1827-1839

 

International Angiology 1998 September;17(3):155-60

    ORIGINAL ARTICLES

Comparative effi­ca­cy of a sin­gle daily dose of two cap­sules Cyclo 3 Fort* in the morn­ing ver­sus a repeat­ed dose of one cap­sule morn­ing and noon. A one-month study

Boc­ca­lon H. *, Causse C. **, Yube­ro L. **

From the * Service d’Angiologie, CHU Rangueil, Toulouse,
** Laboratoire Pierre Fabre Cardiovasculaire, Pierre Fabre Medicament, Castres, France

Background. The effi­ca­cy of Cyclo 3 Fort has pre­vi­ous­ly been dem­on­strat­ed in pla­ce­bo-con­trolled ­trials on ple­thys­mo­graph­ic and clin­i­cal param­e­ters . Its objec­tive was to dem­on­strate that after one month of ther­a­py, the effi­ca­cy and safe­ty of a sin­gle dose of two cap­sules of Cyclo 3 Fort in the morn­ing were com­par­able to that of a twice daily dose of Cyclo 3 Fort, one cap­sule morn­ing and noon.
Methods. This sin­gle-cen­ter, ran­dom­ised, dou­ble-blind study was con­duct­ed on 37 women with chron­ic lower-limb ­venous insuf­fi­cien­cy, asso­ciat­ing clin­i­cal or func­tion­al signs and abnor­mal ple­thys­mo­graph­ic val­ues. Clinical param­e­ters meas­ured were those con­ven­tion­al­ly used to ­assess super­fi­cial ­venous insuf­fi­cien­cy; the main labor­a­to­ry param­e­ter eval­u­at­ed by ple­thys­mog­ra­phy was the index of ­venous dis­ten­sibil­ity.
Results. The ­results data show that in each of the study ­groups, all of the ­patients ­attained a sig­nif­i­cant improve­ment in their clin­i­cal con­di­tions, con­firmed by labor­a­to­ry tests, fol­low­ing one month of ther­a­py with Cyclo 3 Fort. On the other hand, com­par­i­son of ­results data ­between the two ­groups did not objec­ti­fy any sig­nif­i­cant dif­fer­ence ­between the two treat­ment modal­ities.
Conclusions. Thus a sin­gle dose of two cap­sules of Cyclo 3 Fort in the morn­ing ­appears as effec­tive and as well-tol­er­at­ed as a twice daily dose of one cap­sule of Cyclo 3 Fort morn­ing and noon.

language: English


FULL TEXT  REPRINTS

top of page